ArticleACS pharmacology & translational science2022

Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury.

Keith Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.